O	O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	14	17	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	18	31	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	32	38	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T4	B-Entity	B-Entity	39	41	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T4	I-Entity	I-Entity	41	42	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T4	I-Entity	I-Entity	42	48	kappaB	kappaB	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	49	51	in	in	B-PP	IN	O	1	NMOD	O
O	O	O	52	70	lipopolysaccharide	lipopolysaccharide	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	70	71	-	-	B-NP	HYPH	I-cell_line	14	P	I-cell_line
O	O	O	71	81	stimulated	stimulate	I-NP	VBN	I-cell_line	14	NMOD	I-cell_line
O	O	O	82	86	U937	U937	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	87	92	cells	cell	I-NP	NNS	I-cell_line	9	PMOD	I-cell_line
O	O	O	92	93	.	.	O	.	O	1	P	O

O	O	O	95	101	During	During	B-PP	IN	O	13	VMOD	O
O	O	O	102	105	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	106	112	course	course	I-NP	NN	O	1	PMOD	O
O	O	O	113	115	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	116	123	serious	serious	B-NP	JJ	O	6	AMOD	O
O	O	O	124	133	bacterial	bacterial	I-NP	JJ	O	7	NMOD	O
O	O	O	134	144	infections	infection	I-NP	NNS	O	4	PMOD	O
O	O	O	144	145	,	,	O	,	O	13	P	O
O	O	O	146	164	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	13	SUB	O
O	O	O	165	166	(	(	O	(	O	12	DEP	O
O	O	O	166	169	LPS	LPS	B-NP	NN	O	12	DEP	O
O	O	O	169	170	)	)	O	)	O	9	NMOD	O
O	O	O	171	180	interacts	interact	B-VP	VBZ	O	0	ROOT	O
O	O	O	181	185	with	with	B-PP	IN	O	13	VMOD	O
O	O	O	186	194	monocyte	monocyte	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	194	195	/	/	B-VP	SYM	I-protein	18	P	I-protein
O	O	O	195	205	macrophage	macrophage	B-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	206	215	receptors	receptor	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	O	215	216	,	,	O	,	O	13	P	O
O	O	O	217	226	resulting	result	B-VP	VBG	O	13	VMOD	O
O	O	O	227	229	in	in	B-PP	IN	O	20	VMOD	O
O	O	O	230	233	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	234	244	generation	generation	I-NP	NN	O	21	PMOD	O
O	O	O	245	247	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	248	260	inflammatory	inflammatory	B-NP	JJ	B-protein	26	NMOD	B-protein
O	O	O	261	270	cytokines	cytokine	I-NP	NNS	I-protein	24	PMOD	I-protein
O	O	O	270	271	.	.	O	.	O	13	P	O

O	O	O	272	285	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	286	292	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T5	B-Entity	B-Entity	293	295	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T5	I-Entity	I-Entity	295	296	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T5	I-Entity	I-Entity	296	302	kappaB	kappaB	I-NP	NN	I-protein	6	SUB	I-protein
O	O	O	303	305	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	306	313	crucial	crucial	B-ADJP	JJ	O	6	PRD	O
O	O	O	314	316	in	in	B-PP	IN	O	7	AMOD	O
O	O	O	317	327	activating	activate	B-VP	VBG	O	8	PMOD	O
O	O	O	328	331	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	332	345	transcription	transcription	I-NP	NN	O	9	OBJ	O
O	O	O	346	348	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	349	354	genes	gene	B-NP	NNS	B-DNA	12	PMOD	B-DNA
O	O	O	355	363	encoding	encode	B-VP	VBG	O	13	NMOD	O
T6	B-Entity	B-Entity	364	379	proinflammatory	proinflammatory	B-NP	JJ	B-protein	16	NMOD	B-protein
T6	I-Entity	I-Entity	380	389	cytokines	cytokine	I-NP	NNS	I-protein	14	OBJ	I-protein
O	O	O	389	390	.	.	O	.	O	6	P	O

O	O	O	391	393	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	394	398	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	399	404	paper	paper	I-NP	NN	O	1	PMOD	O
O	O	O	404	405	,	,	O	,	O	6	P	O
O	O	O	406	408	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	409	420	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	421	425	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	426	429	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	430	440	activation	activation	I-NP	NN	O	24	SUB	O
O	O	O	441	443	of	of	B-PP	IN	O	9	NMOD	O
T7	B-Entity	B-Entity	444	446	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T7	I-Entity	I-Entity	446	447	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T7	I-Entity	I-Entity	447	453	kappaB	kappaB	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	454	456	by	by	B-PP	IN	O	9	NMOD	O
O	O	O	457	460	LPS	LPS	B-NP	NN	O	14	PMOD	O
O	O	O	461	463	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	464	465	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	466	478	promonocytic	promonocytic	I-NP	JJ	B-cell_line	20	NMOD	B-cell_line
O	O	O	479	483	cell	cell	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	O	484	488	line	line	I-NP	NN	I-cell_line	16	PMOD	I-cell_line
O	O	O	489	490	(	(	O	(	O	23	DEP	O
O	O	O	490	494	U937	U937	B-NP	NN	B-cell_line	23	DEP	B-cell_line
O	O	O	494	495	)	)	O	)	O	20	NMOD	O
O	O	O	496	504	followed	follow	B-VP	VBD	O	7	SBAR	O
O	O	O	505	506	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	507	513	rather	rather	I-NP	RB	O	27	AMOD	O
O	O	O	514	518	slow	slow	I-NP	JJ	O	28	NMOD	O
O	O	O	519	527	kinetics	kinetic	I-NP	NNS	O	24	OBJ	O
O	O	O	527	528	,	,	O	,	O	24	P	O
O	O	O	529	538	depending	depend	B-PP	VBG	O	24	VMOD	O
O	O	O	539	541	on	on	B-PP	IN	O	30	PMOD	O
O	O	O	542	545	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	546	550	rate	rate	I-NP	NN	O	31	PMOD	O
O	O	O	551	553	of	of	B-PP	IN	O	33	NMOD	O
T1	B-Protein	B-Protein	554	561	IkappaB	IkappaB	B-NP	NN	B-protein	39	NMOD	B-protein
T1	I-Protein	I-Protein	561	562	-	-	O	HYPH	O	39	NMOD	O
T1	I-Protein	I-Protein	562	567	alpha	alpha	B-NP	SYM	O	39	NMOD	O
O	O	O	568	577	inhibitor	inhibitor	I-NP	NN	O	39	NMOD	O
O	O	O	578	588	hydrolysis	hydrolysis	I-NP	NN	O	34	PMOD	O
O	O	O	588	589	.	.	O	.	O	6	P	O

O	O	O	590	592	No	No	B-NP	DT	O	2	NMOD	O
O	O	O	593	604	degradation	degradation	I-NP	NN	O	8	SUB	O
O	O	O	605	607	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	608	612	p105	p105	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	613	616	and	and	I-NP	CC	O	7	NMOD	O
O	O	O	617	621	p100	p100	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	622	632	inhibitors	inhibitor	I-NP	NNS	O	3	PMOD	O
O	O	O	633	636	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	637	645	observed	observe	I-VP	VBN	O	8	VC	O
O	O	O	646	651	under	under	B-PP	IN	O	9	VMOD	O
O	O	O	652	657	these	these	B-NP	DT	O	12	NMOD	O
O	O	O	658	668	conditions	condition	I-NP	NNS	O	10	PMOD	O
O	O	O	668	669	.	.	O	.	O	8	P	O

O	O	O	670	673	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	674	686	transduction	transduction	I-NP	NN	O	3	NMOD	O
O	O	O	687	694	pathway	pathway	I-NP	NN	O	13	SUB	O
O	O	O	695	702	leading	lead	B-VP	VBG	O	3	NMOD	O
O	O	O	703	705	to	to	B-PP	TO	O	4	VMOD	O
T8	B-Entity	B-Entity	706	708	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T8	I-Entity	I-Entity	708	709	-	-	I-NP	HYPH	I-protein	8	NMOD	I-protein
T8	I-Entity	I-Entity	709	715	kappaB	kappaB	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	716	726	activation	activation	I-NP	NN	O	5	PMOD	O
O	O	O	727	729	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	730	734	U937	U937	B-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	O	735	740	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	741	749	involved	involve	B-VP	VBD	O	0	ROOT	O
O	O	O	750	753	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	754	767	intracellular	intracellular	I-NP	JJ	O	16	NMOD	O
O	O	O	768	778	generation	generation	I-NP	NN	O	13	OBJ	O
O	O	O	779	781	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	782	790	reactive	reactive	B-NP	JJ	O	20	NMOD	O
O	O	O	791	797	oxygen	oxygen	I-NP	NN	O	20	NMOD	O
O	O	O	798	805	species	specie	I-NP	NNS	O	17	PMOD	O
O	O	O	806	807	(	(	O	(	O	23	DEP	O
O	O	O	807	810	ROS	ROS	B-NP	NN	O	23	DEP	O
O	O	O	810	811	)	)	O	)	O	20	NMOD	O
O	O	O	811	812	,	,	O	,	O	13	P	O
O	O	O	813	815	as	as	B-SBAR	IN	O	13	VMOD	O
O	O	O	816	828	demonstrated	demonstrate	B-VP	VBN	O	25	SBAR	O
O	O	O	829	831	by	by	B-PP	IN	O	26	VMOD	O
O	O	O	832	835	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	836	847	concomitant	concomitant	I-NP	JJ	O	30	AMOD	O
O	O	O	848	858	inhibitory	inhibitory	I-NP	JJ	O	31	NMOD	O
O	O	O	859	866	effects	effect	I-NP	NNS	O	27	PMOD	O
O	O	O	867	869	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	870	882	antioxidants	antioxidant	B-NP	NNS	O	32	PMOD	O
O	O	O	883	885	on	on	B-PP	IN	O	31	NMOD	O
T9	B-Entity	B-Entity	886	888	NF	NF	B-NP	NN	B-protein	38	NMOD	B-protein
T9	I-Entity	I-Entity	888	889	-	-	O	HYPH	I-protein	38	NMOD	I-protein
T9	I-Entity	I-Entity	889	895	kappaB	kappaB	B-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	896	906	activation	activation	I-NP	NN	O	41	NMOD	O
O	O	O	907	910	and	and	O	CC	O	41	NMOD	O
O	O	O	911	914	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	915	923	emission	emission	I-NP	NN	O	34	PMOD	O
O	O	O	924	926	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	927	928	a	a	B-NP	DT	O	45	NMOD	O
O	O	O	929	940	fluorescent	fluorescent	I-NP	JJ	O	45	NMOD	O
O	O	O	941	946	probe	probe	I-NP	NN	O	42	PMOD	O
O	O	O	947	955	reacting	react	B-VP	VBG	O	45	NMOD	O
O	O	O	956	971	intracellularly	intracellularly	B-ADVP	RB	O	46	VMOD	O
O	O	O	972	976	with	with	B-PP	IN	O	46	VMOD	O
O	O	O	977	985	hydrogen	hydrogen	B-NP	NN	O	50	NMOD	O
O	O	O	986	994	peroxide	peroxide	I-NP	NN	O	48	PMOD	O
O	O	O	994	995	.	.	O	.	O	13	P	O

O	O	O	996	1000	This	This	B-NP	DT	O	3	NMOD	O
O	O	O	1001	1004	ROS	ROS	I-NP	NN	O	3	NMOD	O
O	O	O	1005	1012	pathway	pathway	I-NP	NN	O	4	SUB	O
O	O	O	1013	1016	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1017	1021	also	also	I-VP	RB	O	4	VMOD	O
O	O	O	1022	1035	characterized	characterize	I-VP	VBN	O	4	VC	O
O	O	O	1036	1038	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	1039	1042	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1043	1046	use	use	I-NP	NN	O	7	PMOD	O
O	O	O	1047	1049	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1050	1055	other	other	B-NP	JJ	O	12	NMOD	O
O	O	O	1056	1066	inhibitors	inhibitor	I-NP	NNS	O	10	PMOD	O
O	O	O	1066	1067	.	.	O	.	O	4	P	O

O	O	O	1068	1072	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1073	1080	finding	finding	I-NP	NN	O	3	SUB	O
O	O	O	1081	1090	indicates	indicate	B-VP	VBZ	O	0	ROOT	O
O	O	O	1091	1095	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1096	1109	phospholipase	phospholipase	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	1110	1112	A2	A2	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	1113	1116	and	and	O	CC	I-protein	10	NMOD	I-protein
T2	B-Protein	B-Protein	1117	1118	5	5	B-NP	CD	I-protein	10	NMOD	I-protein
T2	I-Protein	I-Protein	1118	1119	-	-	I-NP	HYPH	O	10	NMOD	O
T2	I-Protein	I-Protein	1119	1131	lipoxygenase	lipoxygenase	I-NP	NN	B-protein	11	SUB	B-protein
O	O	O	1132	1135	are	be	B-VP	VBP	O	4	SBAR	O
O	O	O	1136	1140	also	also	I-VP	RB	O	11	VMOD	O
O	O	O	1141	1149	involved	involve	I-VP	VBN	O	11	VC	O
O	O	O	1149	1150	.	.	O	.	O	3	P	O

O	O	O	1151	1158	However	However	B-ADVP	RB	O	17	VMOD	O
O	O	O	1158	1159	,	,	O	,	O	17	P	O
O	O	O	1160	1163	the	the	B-NP	DT	O	8	NMOD	O
T10	B-Entity	B-Entity	1164	1166	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T10	I-Entity	I-Entity	1166	1167	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T10	I-Entity	I-Entity	1167	1173	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	1174	1184	activation	activation	I-NP	NN	O	8	NMOD	O
O	O	O	1185	1192	pathway	pathway	I-NP	NN	O	17	SUB	O
O	O	O	1193	1202	involving	involve	B-VP	VBG	O	8	NMOD	O
O	O	O	1203	1206	the	the	B-NP	DT	O	12	NMOD	O
T3	B-Protein	B-Protein	1207	1213	acidic	acidic	I-NP	JJ	B-protein	12	NMOD	B-protein
T3	I-Protein	I-Protein	1214	1230	sphingomyelinase	sphingomyelinase	I-NP	NN	I-protein	9	OBJ	I-protein
O	O	O	1231	1233	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1234	1237	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1238	1252	endolysosomial	endolysosomial	I-NP	JJ	O	16	NMOD	O
O	O	O	1253	1261	membrane	membrane	I-NP	NN	O	13	PMOD	O
O	O	O	1262	1265	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	1266	1269	not	not	I-VP	RB	O	17	VMOD	O
O	O	O	1270	1274	seem	seem	I-VP	VB	O	17	VC	O
O	O	O	1275	1277	to	to	I-VP	TO	O	21	VMOD	O
O	O	O	1278	1289	participate	participate	I-VP	VB	O	19	VMOD	O
O	O	O	1290	1292	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	1293	1296	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	1297	1300	LPS	LPS	I-NP	NN	O	30	NMOD	O
O	O	O	1300	1301	-	-	B-VP	HYPH	O	30	P	O
O	O	O	1301	1308	induced	induce	B-NP	VBN	O	30	NMOD	O
T11	B-Entity	B-Entity	1309	1311	NF	NF	I-NP	NN	B-protein	29	NMOD	B-protein
T11	I-Entity	I-Entity	1311	1312	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T11	I-Entity	I-Entity	1312	1318	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	1319	1329	activation	activation	I-NP	NN	O	22	PMOD	O
O	O	O	1330	1332	in	in	B-PP	IN	O	30	NMOD	O
O	O	O	1333	1337	U937	U937	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	O	1338	1343	cells	cell	I-NP	NNS	I-cell_line	31	PMOD	I-cell_line
O	O	O	1343	1344	.	.	O	.	O	17	P	O
